Healthcare Defending the Bayh-Dole Act, or why governments shouldn’t dictate the cost of drugs Healthcare / 7 months ago by Nigel Rawson and John Adams, opinion contributors 04/13/24 4:00 PM ET
Healthcare Canadian drugs can’t soothe America’s healthcare pains Healthcare / 9 months ago by Nigel Rawson and John Adams, opinion contributors 02/03/24 8:00 AM ET
Health Care Democrats try to break through on drug pricing message Health Care / 2 years ago by Nathaniel Weixel 10/15/22 3:00 PM ET
Administration HHS: Price of more than 1,200 drugs outpaced inflation Administration / 2 years ago by Joseph Choi 09/30/22 5:12 PM ET
Health Care Senate rules official strikes part of Democrats’ drug pricing measures Health Care / 2 years ago by Peter Sullivan 08/06/22 10:16 AM ET
Congress Blog The Senate’s plan on insulin drugs is the wrong way to solve the affordability problem Congress Blog / 2 years ago by Richard G Frank and Marta E Wosińska, opinion contributors 07/06/22 8:00 PM ET
Health Care Senate Democrats push revised drug pricing plan as they prep larger Biden economic package Health Care / 2 years ago by Peter Sullivan 06/30/22 11:12 AM ET
Health Care AARP ad buy urges Manchin to support Medicare drug negotiation in reconciliation bill Health Care / 2 years ago by Nathaniel Weixel 06/21/22 11:58 AM ET
Health Care House passes bill to cap the cost of insulin Health Care / 3 years ago by Nathaniel Weixel 03/31/22 5:53 PM ET
Healthcare A rising China and progressive policies endanger US pharmaceutical innovation Healthcare / 3 years ago by Brian J. Miller, opinion contributor 03/15/22 3:31 PM ET
White House This SOTU, Biden can win back voters with a plan for lower drug prices White House / 3 years ago by Douglas E. Schoen, opinion contributor 02/27/22 9:01 AM ET
Administration Biden calls on Senate to pass his agenda to lower drug prices Administration / 3 years ago by Peter Sullivan 02/10/22 1:50 PM ET
Healthcare A strategic pivot to healthcare reform could save the midterms for Democrats Healthcare / 3 years ago by Douglas E. Schoen, opinion contributor 01/30/22 9:02 AM ET
Healthcare Proposed drug supply chain rule is mere table ante for broader ‘rebate’ reform Healthcare / 3 years ago by Terry Wilcox, opinion contributor 01/25/22 3:30 PM ET
Health Care Biogen halves price of controversial Alzheimer’s drug Health Care / 3 years ago by Nathaniel Weixel 12/20/21 10:48 AM ET
Health Care House Democrats find drug companies ‘unjustified’ in price hikes Health Care / 3 years ago by Nathaniel Weixel 12/10/21 11:25 AM ET